Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:legal_case
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Sage_Therapeutics
|
| gptkbp:current_use |
Major Depressive Disorder
|
| https://www.w3.org/2000/01/rdf-schema#label |
SAGE-217
|
| gptkbp:is_protected_by |
gptkb:SAGE-217
|
| gptkbp:is_tested_for |
Phase 2
|
| gptkbp:launch_date |
2018-01-01
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:participants |
Change in depression severity
|
| gptkbp:result |
positive efficacy results
|
| gptkbp:sponsor |
SAGE Therapeutics
|
| gptkbp:status |
completed
|
| gptkbp:year |
2019-12-31
|